相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study
Jian-Nan Liu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Identification of Four Immune Subtypes in Bladder Cancer Based on Immune Gene Sets
Chaozhi Tang et al.
FRONTIERS IN ONCOLOGY (2020)
LINC00987 Ameliorates COPD by Regulating LPS-Induced Cell Apoptosis, Oxidative Stress, Inflammation and Autophagy Through Let-7b-5p/SIRT1 Axis
Yuanyuan Wang et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2020)
Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling
Chaozhi Tang et al.
STEM CELL RESEARCH & THERAPY (2020)
Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer
Giuseppe Sammarco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Hypoxia decreases macrophage glycolysis and M1 percentage by targeting microRNA-30c and mTOR in human gastric cancer
Yun Zhihua et al.
CANCER SCIENCE (2019)
Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome
Xiaofan Lu et al.
NEOPLASIA (2019)
Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer
Zhao Zhang et al.
NATURE COMMUNICATIONS (2019)
Tumor Infiltrating Lymphocytes and Macrophages Improve Survival in Microsatellite Unstable Colorectal Cancer
Sumana Narayanan et al.
SCIENTIFIC REPORTS (2019)
From Super-Enhancer Non-coding RNA to Immune Checkpoint: Frameworks to Functions
Manqing Wu et al.
FRONTIERS IN ONCOLOGY (2019)
The Prognostic Landscape of Tumor-Infiltrating Immune Cells and Immune Checkpoints in Glioblastoma
Shiman Wu et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
Metabolic regulation of macrophages in tumor microenvironment
Jaehong Kim et al.
CURRENT OPINION IN HEMATOLOGY (2018)
Enhancer RNA profiling predicts transcription factor activity
Joseph G. Azofeifa et al.
GENOME RESEARCH (2018)
Atezolizumab for the First-Line Treatment of Non-small Cell Lung Cancer (NSCLC): Current Status and Future Prospects
Rachel Ryu et al.
FRONTIERS IN ONCOLOGY (2018)
MYC expression correlates with PD-L1 expression in non-small cell lung cancer
Eun Young Kim et al.
LUNG CANCER (2017)
The fragmentation mechanism and immune-protective effect of CfTEP in the scallop Chlamys farreri
Zhuang Xue et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2017)
Landscape of Microsatellite Instability Across 39 Cancer Types
Russell Bonneville et al.
JCO PRECISION ONCOLOGY (2017)
Long noncoding RNAs in B-cell development and activation
Tiago F. Brazao et al.
BLOOD (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Enhancers as non-coding RNA transcription units: recent insights and future perspectives
Wenbo Li et al.
NATURE REVIEWS GENETICS (2016)
MYC regulates the antitumor immune response through CD47 and PD-L1
Stephanie C. Casey et al.
SCIENCE (2016)
Enhancec Identification of Transcriptional Enhancers Provides Vechanistic Insights into Diseases
Yasuhiro Murakawa et al.
TRENDS IN GENETICS (2016)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Long ncRNA expression associates with tissue-specific enhancers
Dubravka Vucicevic et al.
CELL CYCLE (2015)
Condensin I and II Complexes License Full Estrogen Receptor α-Dependent Enhancer Activation
Wenbo Li et al.
MOLECULAR CELL (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
The selection and function of cell type-specific enhancers
Sven Heinz et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
H. B. Ragnum et al.
BRITISH JOURNAL OF CANCER (2015)
Lung Cancer Incidence Trends by Gender, Race and Histology in the United States, 1973-2010
Rafael Meza et al.
PLOS ONE (2015)
Immunotherapy and lung cancer: current developments and novel targeted therapies
Duarte Domingues et al.
IMMUNOTHERAPY (2014)
Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes
Nicholas E. Iiott et al.
NATURE COMMUNICATIONS (2014)
A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer
Amanda Eustace et al.
CLINICAL CANCER RESEARCH (2013)
New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical Trials
William D. Travis et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
eRNAs Are Required for p53-Dependent Enhancer Activity and Gene Transcription
Carlos A. Melo et al.
MOLECULAR CELL (2013)
eRNAs Promote Transcription by Establishing Chromatin Accessibility at Defined Genomic Loci
Kambiz Mousavi et al.
MOLECULAR CELL (2013)
Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription
Michael T. Y. Lam et al.
NATURE (2013)
Enhancers: five essential questions
Len A. Pennacchio et al.
NATURE REVIEWS GENETICS (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression
Thomas Derrien et al.
GENOME RESEARCH (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Small-cell lung cancer
Jan P. van Meerbeeck et al.
LANCET (2011)
Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro
Brita Singers Sorensen et al.
ACTA ONCOLOGICA (2010)
Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
F. M. Buffa et al.
BRITISH JOURNAL OF CANCER (2010)
alpha 2-Macroglobulin Inhibits the Malignant Properties of Astrocytoma Cells by Impeding beta-Catenin Signaling
Inge Lindner et al.
CANCER RESEARCH (2010)
Widespread transcription at neuronal activity-regulated enhancers
Tae-Kyung Kim et al.
NATURE (2010)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Prostate cancer serum biomarker discovery through proteomic analysis of alpha-2 macroglobulin protein complexes
Earle F. Burgess et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers
Stuart C. Winter et al.
CANCER RESEARCH (2007)
Microsatellite instability and colorectal cancer prognosis
P Benatti et al.
CLINICAL CANCER RESEARCH (2005)
Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases
A Buckowitz et al.
BRITISH JOURNAL OF CANCER (2005)
Plasma levels of transforming growth factor-1β and α2-macroglobulin before and after radical prostatectomy:: Association to clinicopathological parameters
O Sinnreich et al.
PROSTATE (2004)
Human α2-macroglobulin:: genotype-phenotype relation
G Birkenmeier et al.
EXPERIMENTAL NEUROLOGY (2003)
Modulation of growth factor binding properties of α2-macroglobulin by enzyme therapy
D Lauer et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
分享论文
